(Q40478530)

20 September 2017

title

The mitotic spindle checkpoint is a critical determinant for topoisomerase-based chemotherapy. (English)

1 reference

20 September 2017

1 reference

Rolf Müller

3

0 references

author name string

Celia Vogel

series ordinal

1

1 reference

20 September 2017

Anne Kienitz

series ordinal

2

1 reference

20 September 2017

Holger Bastians

series ordinal

4

1 reference

20 September 2017

language of work or name

English

0 references

publication date

16 December 2004

1 reference

Journal of Biological Chemistry

20 September 2017

number of pages

4

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

20 September 2017

volume

280

1 reference

20 September 2017

issue

6

1 reference

20 September 2017

page(s)

4025-4028

1 reference

The spindle checkpoint, aneuploidy, and cancer

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400545200

Microtubules as a target for anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400545200

Mutations of mitotic checkpoint genes in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400545200

Frequent impairment of the spindle assembly checkpoint in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400545200

Variable levels of chromosomal instability and mitotic spindle checkpoint defects in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400545200

Dependence of paclitaxel sensitivity on a functional spindle assembly checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400545200

Association between mitotic spindle checkpoint impairment and susceptibility to the induction of apoptosis by anti-microtubule agents in human lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400545200

Prevalent loss of mitotic spindle checkpoint in adult T-cell leukemia confers resistance to microtubule inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400545200

Anticancer drug targets: cell cycle and checkpoint control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400545200

UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400545200

Potentiation of cytotoxicity of topoisomerase i poison by concurrent and sequential treatment with the checkpoint inhibitor UCN-01 involves disparate mechanisms resulting in either p53-independent clonogenic suppression or p53-dependent mitotic cata

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400545200

Requirement for p53 and p21 to sustain G2 arrest after DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400545200

MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400545200

Mitotic catastrophe constitutes a special case of apoptosis whose suppression entails aneuploidy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400545200

Survivin is required for a sustained spindle checkpoint arrest in response to lack of tension

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400545200

Pleiotropic cell-division defects and apoptosis induced by interference with survivin function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400545200

21 January 2018

Identifiers

DOI

10.1074/JBC.C400545200

1 reference

20 September 2017

1 reference